ANDREWS, U.S. DISTRICT JUDGE:
Presently before the Court are two summary judgment motions filed by Defendants and two Daubert motions, one filed by Plaintiff and one by Defendants. Specifically, Defendants filed a Motion for Summary Judgment of Non-Infringement and No Willfulness (D.I.145), a Motion for Summary Judgment on Damages Issues (D.I.142), and a Motion to Exclude M2M's Experts Richard Bero and Whitey Bluestein (D.I.147).
On January 13, 2012, Plaintiff M2M Solutions LLC filed five related patent infringement actions asserting infringement of U.S. Patent Nos. 8,094,010 ("the `010 patent") and 7,583,197 ("the `197 patent"). The Court held a Markman hearing, after which it invalidated the `197 patent and construed several claim terms in the `010 patent. (D.I.90). The Court issued separate Memorandum Opinions on summary judgment motions (the "Telit SJ opinion") and Daubert motions (the "Telit Daubert opinion") in Plaintiffs related case against Telit. (C.A. No. 12-33-RGA, D.I.247, 295). The parties have since agreed to withdraw certain arguments made in the present motions, conceding that the reasoning of the Telit SJ opinion applies with equal force to certain issues raised here. (D.I. 201 at 1-3).
The `010 patent claims a "programmable communicator device" that is capable of receiving transmissions, authenticating them using a particular form of coded number authentication, and storing numbers from authenticated transmissions in a list of permitted callers. (`010 patent, abstract & claim 1). The patent further contemplates a device that is remotely programmable and that allows for remote data monitoring, "which can be used to relay information about the status of a remote piece of technical equipment such as a vending machine." (Id. col. 3, ll. 43-47; id. col. 4, ll. 3-7; id. col. 7, ll. 24-30).
"The court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law." FED. R. CIV. P. 56(a). The moving party has the initial burden of proving the absence of a genuinely disputed material fact relative to the claims in question. Celotex Corp. v. Catrett, 477 U.S. 317, 330, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). Material facts are those "that could affect the outcome" of the proceeding, and "a dispute about a material fact is `genuine' if the evidence is sufficient to permit a reasonable jury to return a verdict for the nonmoving party." Lamont v. New Jersey, 637 F.3d 177, 181 (3d Cir. 2011) (quoting Anderson v. Liberty Lobby,
The burden then shifts to the non-movant to demonstrate the existence of a genuine issue for trial. Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 586-87, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986); Williams v. Borough of West Chester, Pa., 891 F.2d 458, 460-61 (3d Cir.1989). A non-moving party asserting that a fact is genuinely disputed must support such an assertion by: "(A) citing to particular parts of materials in the record, including depositions, documents, electronically stored information, affidavits or declarations, stipulations ..., admissions, interrogatory answers, or other materials; or (B) showing that the materials cited [by the opposing party] do not establish the absence ... of a genuine dispute...." FED.R.CIV.P. 56(c)(1).
When determining whether a genuine issue of material fact exists, the court must view the evidence in the light most favorable to the non-moving party and draw all reasonable inferences in that party's favor. Scott v. Harris, 550 U.S. 372, 380, 127 S.Ct. 1769, 167 L.Ed.2d 686 (2007); Wishkin v. Potter, 476 F.3d 180, 184 (3d Cir. 2007). A dispute is "genuine" only if the evidence is such that a reasonable jury could return a verdict for the non-moving party. Anderson, 477 U.S. at 247-49, 106 S.Ct. 2505. If the non-moving party fails to make a sufficient showing on an essential element of its case with respect to which it has the burden of proof, the moving party is entitled to judgment as a matter of law. See Celotex Corp., 477 U.S. at 322, 106 S.Ct. 2548.
Federal Rule of Evidence 702 sets out the requirements for expert witness testimony and states:
FED.R.EVID. 702. The Third Circuit has explained:
Schneider ex rel. Estate of Schneider v. Fried, 320 F.3d 396, 404-05 (3d Cir.2003) (footnote and internal citations omitted).
The party offering expert testimony bears the burden of proving its admissibility by a preponderance of the evidence. See Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579, 592 n.10, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). In the context of calculating a reasonably royalty in a patent case under 35 U.S.C. § 284, the Federal Circuit has explained that "damages awarded for patent infringement must reflect the value attributable to the infringing features of the product, and no more." CSIRO v. Cisco Sys., Inc., 809 F.3d 1295, 1301 (Fed.Cir.2015) (internal quotation marks omitted). "[G]iven the great financial incentive parties have to exploit the inherent imprecision in patent valuation, courts must be proactive to ensure that the testimony presented — using whatever methodology — is sufficiently reliable to support a damages award." Id. Further, the Federal Circuit has "consistently explained that proof of damages must be carefully tied to the claimed invention itself." Apple Inc. v. Motorola, Inc., 757 F.3d 1286, 1324 (Fed.Cir.2014); see also VirnetX, Inc. v. Cisco Sys., Inc., 767 F.3d 1308, 1327 (Fed.Cir.2014) ("[T]his court has consistently held that a reasonable royalty analysis requires a court to... carefully tie proof of damages to the claimed invention's footprint in the market place." (alteration in original) (internal quotation marks omitted)). "While questions regarding which facts are most relevant for calculating a reasonable royalty are properly left to the jury, a critical prerequisite is that the underlying methodology be sound." VirnetX, 767 F.3d at 1328. "[T]he essential requirement for reliability under Daubert is that the ultimate reasonable royalty award must be based on the incremental value that the patented invention adds to the end product." CSIRO, 809 F.3d at 1301 (internal quotation marks omitted).
Defendants' non-infringement and no willfulness motion raises three principal issues. First, Defendants argue that their accused products do not infringe because they do not satisfy the "permitted callers" limitation of the `010 patent. (D.I. 146 at 14-19). Second, they argue that the `010 patent is not drawn to functional capability and that proving infringement therefore requires a showing, not made by Plaintiff, that the accused products have actually performed the function of authenticating incoming transmissions. (Id. at 19-22). Third, Defendants argue that they are entitled to summary judgment of no willful infringement. (Id. at 23-24).
With respect to its remaining argument regarding the "permitted caller" limitation, Defendants argue that the accused products do not meet the permitted caller limitation because the accused products "do not accept only calls from permitted callers, and reject all calls from non-permitted callers, as the `permitted callers' limitation requires." (D.I. 146 at 14). Defendants argue that this Court's claim construction inherently requires that the "device reject or ignore calls from non-permitted callers — i.e., callers whose numbers are not contained in the `permitted callers' list." (Id. at 15). Plaintiff's infringement theory is that two features in the accused products can serve as a permitted callers list under the Court's construction: (1) the SMSDA White List, or (2) the Friends Firewall. (Id. at 16 (citing D.I. 152-2 at 10-12, ¶¶ 38-43)). Defendants assert that their expert, Dr. Negus, tested the accused SMSDA White List and Friends Firewall features in the accused products and concluded that "even when the lists were enabled and populated with a telephone number or IP address, the accused products still did not reject or ignore such incoming calls from non-permitted callers." (Id. at 16 (citing D.I. 152-7 at ¶¶ 71, 73, 75, 77, & 189)). Thus, Defendants argue that, because Plaintiff does not contest the validity of these results per se, Defendants' "evidence is unrebutted that the accused products do not reject many types of real `calls'... from unlisted numbers and addresses," and therefore do not infringe. (Id. at 17).
Plaintiff argues that Defendants do "not dispute that the SMSDA white list and the Modem Friends firewall list features in its accused products may well be capable of screening `certain types' of incoming calls in the manner required by the Court's construction," but instead Defendants
A patent is infringed when a person "without authority makes, uses or sells any patented invention, within the United States ... during the term of the patent...." 35 U.S.C. § 271(a). A two-step analysis is employed in making an infringement determination. See Markman v. Westview Instruments, Inc., 52 F.3d 967, 976 (Fed.Cir.1995) (en banc), aff'd, 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996). First, the court must construe the asserted claims to ascertain their meaning and scope. See id. Second, the trier of fact must then compare the properly construed claims with the accused infringing product. See id. This second step is a question of fact. See Bai v. L & L Wings, Inc., 160 F.3d 1350, 1353 (Fed.Cir.1998).
"Literal infringement of a claim exists when every limitation recited in the claim is found in the accused device." Kahn v. Gen. Motors Corp., 135 F.3d 1472, 1477 (Fed.Cir.1998). "If any claim limitation is absent from the accused device, there is no literal infringement as a matter of law." Bayer AG v. Elan Pharm. Research Corp., 212 F.3d 1241, 1247 (Fed.Cir. 2000). If an accused product does not infringe an independent claim, it also does not infringe any claim depending thereon. See Wahpeton Canvas Co. v. Frontier, Inc., 870 F.2d 1546, 1553 (Fed.Cir.1989). The patent owner has the burden of proving infringement and must meet its burden by a preponderance of the evidence. See SmithKline Diagnostics, Inc. v. Helena Lab. Corp., 859 F.2d 878, 889 (Fed.Cir. 1988). When an accused infringer moves for summary judgment of noninfringement, such relief may be granted only if at least one limitation of the claim in question does not read on an element of the accused product, either literally or under the doctrine of equivalents. See Chimie v. PPG Indus., Inc., 402 F.3d 1371, 1376 (Fed.Cir. 2005); see also TechSearch, L.L.C. v. Intel Corp., 286 F.3d 1360, 1369 (Fed.Cir.2002) ("Summary judgment of noninfringement is ... appropriate where the patent owner's proof is deficient in meeting an essential part of the legal standard for infringement, because such failure will render all other facts immaterial."). "Thus, summary judgment of non-infringement can only be granted if, after viewing the alleged facts in the light most favorable to the non-movant, there is no genuine issue as to whether" the accused product is covered by the claims (as construed by the court). Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1304 (Fed.Cir. 1999).
I conclude that Defendants are not entitled to summary judgment based on their argument that the "permitted caller" limitation is not met, as they misconstrue what the `010 patent and my claim construction
('010 patent, claim 1 (col.12, ll.38-43)). I construed the term permitted caller to mean "[a] telephone number or IP address on a list of numbers that are designated to cause the programmable communicator to accept an incoming call received from that number." (D.I. 90 at 6-8). In the Telit SJ opinion, I held that the "memory module" claim limitation of the `010 patent, where the permitted caller term appears, is drawn to functional capability. (C.A. 12-33-RGA, D.I. 247 at 9-10; id. at 12-13 ("The language of the `memory module' claim limitation similarly provides additional structure to describe the operation of the stated `storing' function.... I conclude that the `010 patent contains apparatus claims with functional limitations....")).
The fact that the memory module limitation is directed to functional capability means that the infringement inquiry with regard to this limitation is whether the accused feature is capable of performing the function of storing telephone numbers or IP addresses from authenticated transmissions in a permitted callers list. ('010 patent, col. 12, ll. 38-43). To meet the permitted caller term within that limitation, in turn, the features accused of meeting that limitation must be capable of "caus[ing] the programmable communicator to accept an incoming call received" from a number on the list. (D.I. 90 at 6-8). Defendants' position is that the converse of my construction of permitted caller must be true, in other words, that my construction implicitly requires that a permitted callers list "not accept" calls from numbers not on the list. Even assuming this is the case,
Plaintiff's expert, Dr. Nettleton, opines that the SMSDA white list "can store up to five different telephone numbers corresponding to remote devices" and "[t]he telephone numbers stored in populated SMSDA white lists are the only originating telephone numbers from which the Enabler IIIG modules will accept incoming specially formatted AT Commands Over SMS data messages for processing by their firmware." (D.I. 152-2 at 10, ¶¶ 38-39). If incoming commands are from a
While Dr. Negus's testimony may be unrebutted in showing that the accused products do not automatically reject all types of calls from numbers not on a permitted callers list, it does nothing to assist the trier of fact in its relevant inquiry into whether the accused products are capable of employing the SMSDA white list or Modem Friends firewall features in a manner consistent with the permitted caller limitation. As Plaintiff puts it, Dr. Negus's product testing "demonstrat[es] the unremarkable proposition that the accused `permitted callers' list features do not serve to screen certain types of incoming calls that they are not designed to screen." (D.I. 172 at 14). Plaintiff further explains that "the accused SMSDA white lists are designed to screen a certain specially formatted type of incoming SMS data messages," and "the accused Modem Friends firewall lists are designed to screen a certain specially formatted type of incoming UPD/EP data messages," yet Dr. Negus only shows that these features do not screen other types of incoming transmissions that they are not designed to screen. (Id. at 14-15 (citing D.I. 152-7 at 11-16, ¶¶ 68-82)).
Aside from the fact that the `010 patent claims functional capability, Defendants' non-infringement argument is fundamentally inconsistent with my claim construction in another respect. In the claim construction opinion, I rejected Defendants' argument that the specification required the permitted callers list to cause the device to ring or answer (as opposed to using "accept"), reasoning that "Defendants' construction that would require the programmable communicator to `ring or answer' is too narrow." (D.I. 90 at 8). I explained that requiring a ring or answer "would read the optional features of a described embodiment into the claims," when "other disclosed embodiments ... are based on data messages that do not require the answering limitation." (Id. (citing `010 patent, col. 3, ll. 43-52; id. col. 4, ll. 8-13)). I subsequently denied Plaintiffs motion for reconsideration that sought to change the word "call," in the construction of permitted caller, to "transmission," again reiterating that my original construction did not read out "disclosed embodiments, or their accompanying data messages," such as "circuit-switched Calls, SMS data messages, and packet-switched data messages." (D.I. 107 at 4).
Defendants' position now is that the converse of my construction of "permitted caller" must be true, in other words, that my construction implicitly requires that a permitted callers list "not accept" calls from numbers not on the list. (D.I. 146
For the reasons discussed above, Defendants have not established that there are no genuine issues of material fact as to whether the accused products meet the permitted caller limitation. Therefore, Defendants are not entitled to summary judgment of non-infringement on these grounds. See Pitney Bowes, 182 F.3d at 1304.
The second Georgia-Pacific factor, which is implicated by this Daubert motion, looks at "[t]he rates paid by the licensee for the use of other patents comparable to the patent in suit." Georgia-Pacific Corp. v. U.S. Plywood Corp., 318 F.Supp. 1116, 1120 (S.D.N.Y.1970). "This factor examines whether the licenses relied upon ... in proving damages are sufficiently comparable to the hypothetical license at issue in suit." Lucent Techs., Inc. v. Gateway, Inc., 580 F.3d 1301, 1325 (Fed. Cir.2009). "[T]here must be a basis in fact to associate the royalty rates used in prior licenses to the particular hypothetical negotiation at issue." Uniloc USA, Inc. v. Microsoft Corp., 632 F.3d 1292, 1317 (Fed. Cir.2011). It is improper to "rely on license agreements that were radically different from the hypothetical agreement under consideration to determine a reasonable royalty." Id. at 1316 (internal quotation marks omitted). "[C]omparisons of past patent licenses to the infringement must account for the technological and economic differences between them." Wordtech Sys., Inc. v. Integrated Networks Solutions, Inc., 609 F.3d 1308, 1320 (Fed.Cir. 2010) (internal quotation marks omitted). "When relying on licenses to prove a reasonable royalty, alleging a loose or vague comparability between different technologies or licenses does not suffice." LaserDynamics, Inc. v. Quanta Computer, Inc., 694 F.3d 51, 79 (Fed.Cir.2012). "The testimony of a damages expert in a patent suit who relies on non-comparable licenses in
Defendants' damages expert, Dr. William S. Choi, relies on two license agreements to support his reasonable royalty analysis: (1) a May 31, 2013 confidential settlement agreement and license between Company A and Enfora ("the Company A license"), and (2) a May 29, 2012 settlement and patent license agreement between Company B and Enfora ("the Company B license").
Plaintiff moves to exclude the testimony of Dr. Choi to the extent he relies on the Company A and Company B license agreements, on the grounds that these licenses are not technologically or economically comparable to the patent-in-suit. (D.I. 141 at 4).
The settlement agreement between Company A and Enfora took place on May 31, 2013, almost a year and a half after the hypothetical negotiation at issue here. (D.I. 143-3 at 10). Enfora agreed to pay $195,000 to settle the litigation and take a worldwide nonexclusive license to five U.S. patents, as opposed to the single U.S. patent at issue here. (Id. at 4, 7). The license itself was titled "GPS Patent License Agreement" and all five patents relate to vehicle-tracking technology. (Id. at
(D.I. 143-1 at 32, ¶ 62 (footnotes omitted)).
The settlement and patent license agreement between Company B and Enfora was entered into on May 29, 2012, only several months after the hypothetical negotiation here. (D.I. 143-4 at 10). Enfora agreed to pay $145,000 to settle the litigation and take a worldwide, nonexclusive license to U.S. Patent No. 5,223, 844, titled "Vehicle Tracking and Security." (Id. at 2, 4). The agreement indicated that Company B calculated a settlement payment of $290,000, but agreed to a discount of 50% "in recognition of early settlement and other considerations." (Id. at 4). Dr. Choi provides a comparability analysis between the Company B license and the `010 patent that is practically identical to that he provided with regard to the Company A license, again relying on Dr. Negus. (D.I. 143-1 at 32-33, ¶ 63). Dr. Negus also provides an almost identical recitation of comparability to that he provided for the Company A license agreement. (D.I. 143-6 at 3-4, ¶ 436).
I conclude that Plaintiff has not met its burden of demonstrating that there is "a basis in fact to associate the royalty rates used in [these] prior licenses to the particular hypothetical negotiation at issue in [this] case." Uniloc, 632 F.3d at 1317. First, Dr. Choi provides little more than ambiguous conclusions of technological comparability between the two license agreements and the `010 patent, without any rationale other than undisclosed conversations with Dr. Negus. Yet both Dr. Choi and Dr. Negus make almost zero reference to the specific technology involved in either the'010 patent or the Company A and Company B licenses, aside from the hazy reasoning that they all relate to product features rather than core technology. See VirnetX, 767 F.3d at 1326 (reiterating that royalty estimates must focus on "damages attributable to the infringing features"). These loose, vague
Second, and most importantly, with regard to economic comparability, Dr. Choi's analysis virtually ignores the fact that these two licenses resulted from litigation settlements, providing a drastically different backdrop than the hypothetical negotiation involving two willing licensors, as would be the case here. Federal Circuit precedent is hostile toward using litigation settlement agreements in proving a reasonable royalty, except in limited circumstances. See LaserDynamics, 694 F.3d at 77-78 ("The notion that license fees that are tainted by the coercive environment of patent litigation are unsuitable to prove a reasonable royalty is a logical extension of Georgia-Pacific, the premise of which assumes a voluntary agreement will be reached between a willing licensor and a willing licensee...."); ResQNet.com v. Lansa, Inc., 594 F.3d 860, 870-72 (Fed.Cir. 2010) (allowing testimony regarding settlement license for patent-in-suit that was "the most reliable license in [the] record," when compared to licenses that did not "mention[] the patents in suit or show[] any other discernible link to the claimed technology"). The settlement licenses here were not for the patent-in-suit and are only connected to the claimed invention by vague conclusions from Defendants' experts. Dr. Choi makes no effort to account for the fact that these agreements were litigation settlements. He provides no background information about the litigation preceding these agreements or the overall context of the settlements. Instead, Dr. Choi ignores the settlement context altogether and focuses on the fact that the licenses were between Enfora and a non-practicing entity. Under Dr. Choi's rationale, any license between Enfora and a non-practicing entity would be economically comparable to a hypothetical negotiation between Enfora and a different non-practicing entity, regardless of the specific technology or whether the licenses resulted from litigation settlements. These unsubstantiated conclusions about economic comparability, lacking in analysis, again provide nothing more than ipse dixit. Accordingly, there is no showing that the Company A and Company B licenses are economically comparable to the `010 patent. Dr. Choi has failed to account for the economic differences between the `010 patent and the two asserted license agreements. See Wordtech, 609 F.3d at 1320.
Lastly, I find little merit in Defendants' argument that Dr. Choi can use incomparable licenses in his reasonable royalty analysis if he only uses them as a "sanity check," rather than using them to drive the analysis. Federal Circuit precedent requires that for a license to be used in a damages analysis, the license must be proven comparable to the hypothetical negotiation. See, e.g., Lucent Techs., 580 F.3d at 1325. Defendants cannot escape this requirement by suggesting that the incomparable licenses only played a minor role as a quantitative reference point, instead of being a driving force in the reasonable royalty estimate. In sum, Defendants have not met their burden of establishing that the Company A and Company B licenses that Dr. Choi relies upon are sufficiently
Defendants move to exclude to the testimony of Plaintiffs damages experts Richard Bero and Whitey Bluestein. (D.I.147). Defendants raise arguments (D.I.148) that are almost identical to those I considered in the Telit Daubert opinion (C.A. No., D.I.295). In the Telit case, I excluded the testimony of Mr. Bluestein and Mr. Bero for employing an unreliable methodology in calculating damages. (Id. at 5-14). Mr. Bluestein and Mr. Bero use the same methodology here, rendering the Telit Daubert opinion dispositive as to Defendants' current motion. Accordingly, I will grant Defendants' motion to exclude their testimony.
Defendants' Motion for Summary Judgment on Damages Issues raises two arguments. First, Defendants argue for summary judgment that no damages can be awarded for products manufactured and shipped abroad, for not falling under the purview of 35 U.S.C. § 271. (D.I. 144 at 12-13). Second, Defendants argue that the Court should grant summary judgment that damages can be no greater than $120,000, to properly reflect the minimal costs of implementing acceptable, non-infringing alternatives. (Id. at 13-22). For the reasons that follow, I will grant Defendants' motion as to the first issue, and deny Defendants' motion on the second issue.
Defendants argue that products manufactured and shipped abroad are not subject to damages for infringement. (D.I. 144 at 12-13). Defendants contend that Mr. Bero's damages assessment, which calculates damages based on all worldwide sales of Defendants' products,
I extensively considered identical arguments in the Telit SJ opinion. (C.A. No. 12-33-RGA, D.I. 247 at 35-48). I stated the relevant legal framework there. (Id. at 35-38, 45-46). The crux of my opinion in the Telit case was that where, as here, a defendant's products are manufactured abroad and shipped abroad to a foreign
The situation presented here is nearly identical to that considered in the Telit SJ opinion. Accordingly, the rationale of the Telit SJ opinion applies with equal force here. As with Telit, the products at issue here, which are manufactured abroad and shipped to destinations abroad, amount to "domestic contracts for foreign sales." (Id. at 42). Therefore, it is Plaintiffs burden to offer evidence of which products shipped abroad actually made it to the U.S. and are therefore subject to 35 U.S.C. § 271. As in the Telit case, Plaintiffs expert again employs an all-or-nothing approach, seeking to assess damages on Defendants' worldwide sales, rather than presenting facts or a data-backed estimate of how many products shipped abroad actually reach the U.S. Plaintiff's approach is plainly insufficient to overcome the presumption against extraterritoriality. See, e.g., Microsoft v. AT & T Corp., 550 U.S. 437, 454-55, 127 S.Ct. 1746, 167 L.Ed.2d 737 (2007) ("The presumption that United States law governs domestically but does not rule the world applies with particular force in patent law."); Lake Cherokee Hard Drive Techs., L.L.C. v. Marvell Semiconductor, Inc., 964 F.Supp.2d 653, 655-56 (E.D.Tex.2013) ("Any doubt regarding whether conduct falls outside the purview of United States patent law should be resolved by the presumption against extraterritoriality." (citing Microsoft, 550 U.S. at 454, 127 S.Ct. 1746)).
Plaintiff argues that the Court's rationale from the Telit SJ opinion should not apply here, because the facts here are distinguishable. (D.I. 201 at 2). Specifically, Plaintiff asserts that Defendants' Rule 30(b)(6) representative, Ron Schooler, admitted that he is aware that some of Defendants' customers may request that products purchased be shipped to contract manufacturers abroad, even though the products eventually end up in the U.S. (Id.). Indeed, Mr. Schooler admitted during his deposition that customers do this from time of time. (D.I. 175-1 at 29). He identified one company that did this (Company C), and indicated that Company C was Defendants' largest customer.
Implicit in Plaintiff's later assertion of these admissions seems to be an argument that Plaintiff should be able to include sales to Company C that are shipped abroad in its damages calculation. The Court is not aware, however, of any expert opinion that includes only sales to Company C within Plaintiffs damages estimate and Plaintiff has never made this argument. The issue presently before the Court is whether Plaintiff may seek damages on all of Defendants' sales that were manufactured and shipped abroad, with only proof that a single customer of Defendants sometimes imports products shipped abroad into the U.S. I conclude that Plaintiff
Defendants argue that — because their technical expert, Dr. Kevin Negus, presented unrebutted testimony that a commercially acceptable, non-infringing alternative could be implemented for no more than $60,000 — the Court should limit Plaintiffs potential damages to $120,000 with a summary judgment ruling. (D.I. 144 at 13-22). In light of Dr. Negus's testimony, Defendants' damages expert, Dr. Choi, opined that a reasonable royalty would have been no greater than $120,000, in light of the direct and indirect costs to implement one of those non-infringing alternatives. (Id. at 14-15 (citing D.I. 152-12 at ¶¶ 2, 87)). More specifically, Dr. Negus opined that Defendants could have implemented at least three commercially-acceptable alternatives that would not infringe, summarized in Defendants' brief as follows:
(Id. at 14 (citing D.I. 152-7 at 60-63, ¶¶ 411-12, 414)). Defendants argue that Plaintiff has not provided any credible evidence to rebut Dr. Negus's testimony that these various alternatives were non-infringing, commercially acceptable, and available at the ease and cost outlined. (Id. at 15). Specifically, Defendants point out that the only evidence Plaintiff presents to counter this testimony is the unsupported opinion of Mr. Bluestein, a non-technical expert whose testimony has since been excluded by this Court. (Id. at 15-21; D.I. 210 at 1). Thus, Defendants contend that — because the opinions of Dr. Negus and Dr. Choi on the cost, availability, and commercial acceptability of non-infringing alternatives stand unrebutted — there are no genuine issues of material fact and damages in the case should be limited to $120,000.
Plaintiff originally contended — relying on the opinions of Mr. Bluestein and his analysis of the Beacham Reports — that Dr. Negus's proposed alternatives would not be commercially acceptable to a significant amount of customers, were not available at the time of the hypothetical negotiation, and that Defendants' sales may not have been the same without the accused features. (D.I. 174 at 10-18 (citing D.I. 175-6 at 3-5, ¶¶ 5-6, 8)).
I have already excluded Mr. Bluestein's testimony in this case and the Telit case, and I likewise find that he is not qualified to testify, relying on the unrelated Beacham Reports or otherwise, as to whether Defendants' proposed design around would be commercially acceptable, feasible, or non-infringing. (See generally C.A. No. 12-33-RGA, D.I. 295 at 5-14). Yet while Defendants are busy pointing out the lack of remaining expert testimony challenging Dr. Negus's conclusions, they still must also prove their entitlement to judgment as a matter of law in order to warrant summary judgment.
Mars, Inc. v. Coin Acceptors, Inc., 527 F.3d 1359, 1373 (Fed.Cir.2008). Likewise, while the existence of a non-infringing alternative "is a factor relevant to the determination of a proper royalty during hypothetical negotiations," it remains just that, a factor, and does not conclusively establish an upper limit on a reasonably royalty. See Zygo Corp. v. Wyko Corp., 79 F.3d 1563, 1571-72 (Fed.Cir.1996). That this is the state of the law makes a great deal of sense, to the extent that it is almost tautological. It remains the province of the jury to credit or discredit the opinions of Dr. Choi and Dr. Negus as to the feasibility, commercial acceptability, cost, and availability of their proposed, non-infringing alternatives. See, e.g., Apple Inc. v. Motorola, Inc., 757 F.3d 1286, 1314 (Fed. Cir.2014) ("An expert may provide expert testimony based on a valid and properly applied methodology and still offer a conclusion that is subject to doubt. It is the role of the jury to weigh these sources of doubt.... [T]he jury must still be allowed to play its essential role as the arbiter of the weight and credibility of expert testimony." (internal quotation marks omitted)).
Despite the exclusion of Plaintiff's current damages theory, I assume that if this case reaches trial, Plaintiff will offer some theory of damages. Any damages opinion ultimately suggesting a reasonable royalty other than $120,000 will create a factual dispute for the jury to decide. In any event, of even greater significance for purposes of this motion, expert testimony is not necessary to render the proper amount of damages a disputed issue. See Dow Chemical Co. v. Mee Indus., Inc., 341 F.3d 1370, 1382 (Fed.Cir.2003) ("[S]ection 284 is clear that expert testimony is not necessary to the award of damages, but rather `may [be] received[d] ... as an aid.'" (quoting 35 U.S.C. § 284) (alterations in original)). While Defendants criticize Plaintiff for offering attorney argument criticizing Dr. Negus's conclusions, Plaintiff may seek to discredit Dr. Negus's conclusions through cross-examination. "[G]iven the great financial incentive parties
For the reasons set forth above, the Court will grant-in-part and deny-in-part Defendants' Motion for Summary Judgment of Non-Infringement and No Willfulness (D.I.145), grant-in-part and deny-in-part Defendants' Motion for Summary Judgment on Damages Issues (D.I.142), grant Defendants' Motion to Exclude M2M's Damages Experts Richard Bero and Whitey Bluestein (D.I.147), and grant Plaintiffs Motion to Exclude Opinions of Dr. Choi (D.I.140). A separate order, consistent with this Memorandum Opinion, will be entered.
At Wilmington, this 9 day of March, 2016, consistent with the opinion issued this same day;
Defendants also move for summary judgment of no infringement under the doctrine of equivalents, arguing that Plaintiff and its experts have not alleged any theory of infringement under the doctrine of equivalents. (D.I. 146 at 22). Plaintiff essentially admits that it has no doctrine of equivalents infringement theory by declining to respond to this argument in its briefing. Accordingly, because Plaintiff does not present any disputed issues of material fact or credible legal arguments, Defendants are entitled to summary judgment of no infringement under the doctrine of equivalents.